TUMOUR INFLAMMATION-ASSOCIATED NEUROTOXICITY

TUMOUR INFLAMMATION-ASSOCIATED NEUROTOXICITY was reported 7 times

TUMOUR INFLAMMATION-ASSOCIATED NEUROTOXICITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LISOCABTAGENE MARALEUCEL 2 0.0023
1 AXICABTAGENE CILOLEUCEL 2 0.0002
2 BLINATUMOMAB 1 0.0001
3 IRINOTECAN HYDROCHLORIDE 1 0.0001
4 FLUDARABINE PHOSPHATE 2 0.0001
5 DURVALUMAB 1 0.0000
6 LEVETIRACETAM ORAL 2 0.0000
7 LEVETIRACETAM INJECTION 2 0.0000
8 CYTARABINE 1 0.0000
9 LEVETIRACETAM 2 0.0000
10 CISPLATIN 1 0.0000
11 CYCLOPHOSPHAMIDE FOR INJECTION 2 0.0000
12 CYCLOPHOSPHAMIDE 2 0.0000
13 METHYLPREDNISOLONE 1 0.0000
14 DEXAMETHASONE 1.5 MG 2 0.0000
15 DEXAMETHASONE 2 0.0000
16 METHOTREXATE SODIUM 1 0.0000